This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of
Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join
the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
I'm guessing it has been "unofficially adopted" as the nonproprietary name (INN) stem for CETP inhibitors, like -coxib for COX 1/2 inhibitors. I can't find it in the online version of the "stem book" [
[1]], so I'm guessing that it's either not been formalized by whatever body updates the INN system.. Who makes changes in INN stem naming conventions "official" anyway?
This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of
Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join
the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
I'm guessing it has been "unofficially adopted" as the nonproprietary name (INN) stem for CETP inhibitors, like -coxib for COX 1/2 inhibitors. I can't find it in the online version of the "stem book" [
[1]], so I'm guessing that it's either not been formalized by whatever body updates the INN system.. Who makes changes in INN stem naming conventions "official" anyway?